Skip to main content
. 2018 Jun 8;13(6):e0197327. doi: 10.1371/journal.pone.0197327

Table 1. Patients’ demographics and tumor’s characteristics.

Frequency %
Age (range) 65 (18–88)
<70 260 65,5
> = 70 137 34,5
Gender
Male 246 62,0
Female 151 38,0
Stage
IIA-IIIC 202 50,9
IV 195 49,1
Location
Colon/Sigmoid 279 70,3
Rectum 118 29,7
PS (ECOG)
0–1 372 93,7
> = 2 25 6,3
Radiotherapy
Yes 80 20,4
No 313 79,6
Adjuvant Treatment
Yes 230 58,7
No 162 41,4
First Line Treatment
Yes 223 56,2
No 174 46,8
Grade
High 205 47,4
Low 228 52.6
TLR2 196-to -174 del
ins/del 93 23,4
del/del 304 76,6
TLR4 Asp299Gly (A/G)
AA 11 2,8
AG 106 26,7
GG 280 70,5
TLR4 Thr399Ile (T/C)
CC 11 2,8
CT 106 26,7
TT 280 70,5
TLR9 T1237C
TC 153 38,5
CC 244 61,5
TLR9 T1486C
TC 153 38,5
CC 244 61,5
KRAS
Mutant 104 42,4
Wt 141 57,6
ND 152